Comparison of different methods for detecting epidermal growth factor receptor mutations in peripheral blood and tumor tissue of non-small cell lung cancer as a predictor of response to gefitinib

References

• RuschVBaselgaJCordon-CardoCDifferential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lungCancer Res19935310 Suppl237923857683573
   PubMed Web of Science ®Google Scholar
• SalomonDSBrandtRCiardielloFNormannoNEpidermal growth factor-related peptides and their receptors in human malignanciesCrit Rev Oncol Hematol19951931832327612182
   PubMed Web of Science ®Google Scholar
• FukuokaMYanoSGiacconeGMulti-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected]J Clin Oncol200321122237224612748244
   PubMed Web of Science ®Google Scholar
• ShepherdFARodrigues PereiraJCiuleanuTErlotinib in previously treated non-small-cell lung cancerN Engl J Med2005353212313216014882
   PubMed Web of Science ®Google Scholar
• LynchTJBellDWSordellaRActivating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinibN Engl J Med2004350212129213915118073
   PubMed Web of Science ®Google Scholar
• PaezJGJännePALeeJCEGFR mutations in lung cancer: correlation with clinical response to gefitinib therapyScience200430456761497150015118125
   PubMed Web of Science ®Google Scholar
• HuangSFLiuHPLiLHHigh frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in TaiwanClin Cancer Res200410248195820315623594
   PubMed Web of Science ®Google Scholar
• KosakaTYatabeYEndohHKuwanoHTakahashiTMitsudomiTMutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implicationsCancer Res200464248919892315604253
   PubMed Web of Science ®Google Scholar
• PaoWMillerVZakowskiMEGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinibProc Natl Acad Sci U S A200410136133061331115329413
   PubMed Web of Science ®Google Scholar
• ShigematsuHLinLTakahashiTClinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancersJ Natl Cancer Inst200597533934615741570
   PubMed Web of Science ®Google Scholar
• TokumoMToyookaSKiuraKThe relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancersClin Cancer Res20051131167117315709185
   PubMed Web of Science ®Google Scholar
• EttingerDSAkerleyWBeplerGNCCN Non-Small Cell Lung Cancer Panel MembersNon-small cell lung cancerJ Natl Compr Canc Netw20108774080120679538
   PubMed Web of Science ®Google Scholar
• D’AddarioGFrühMReckMESMO Guidelines Working GroupMetastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnn Oncol201021Suppl 5v116v11920555059
   PubMed Web of Science ®Google Scholar
• AzzoliCGBakerSJrTeminSAmerican Society of Clinical OncologyAmerican Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancerJ Clin Oncol200927366251626619917871
   PubMed Web of Science ®Google Scholar
• BellDWLynchTJHaserlatSMEpidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: molecular analysis of the IDEAL/INTACT gefitinib trialsJ Clin Oncol200523318081809216204011
   PubMed Web of Science ®Google Scholar
• TsaoMSSakuradaACutzJCErlotinib in lung cancer – molecular and clinical predictors of outcomeN Engl J Med2005353213314416014883
   PubMed Web of Science ®Google Scholar
• KimuraHSuminoeMKasaharaKEvaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of response to gefitinib (IRESSA)Br J Cancer200797677878417848912
   PubMed Web of Science ®Google Scholar
• MoranTPas-AresLIslaDHigh correspondence between EGFR mutations in tissue and in circulating DNA form non-small-cell lung cancer (NSCLC) patients (p) with poor performance status (PS). 2007 ASCO Annual Meeting Proceedings Part IJ Clin Oncol20072518S, June 20 Supplement7505
   Google Scholar
• RosellRMoranTQueraltCSpanish Lung Cancer GroupScreening for epidermal growth factor receptor mutations in lung cancerN Engl J Med20093611095896719692684
   PubMed Web of Science ®Google Scholar
• BaiHMaoLWangHSEpidermal growth factor receptor mutations in plasma DNA samples predict tumor response in Chinese patients with stages IIIB to IV non-small-cell lung cancerJ Clin Oncol200927162653265919414683
   PubMed Web of Science ®Google Scholar
• LuSYangHYeXA novel mutant-enriched liquidchip for detection of circulating EGFR mutations in advanced non-small cell lung cancer patientsJ Clin Oncol200927Suppl Abstr e14526
   Google Scholar
• TravisWColbyTVCorrinBHistologic Typing of Tumors of Lung and Pleura: World Health OrganizationInternational Classification of Tumors3rd editionNew York, NYSpringer Verlag1999
   Google Scholar
• TherassePArbuckSGEisenhauerEANew guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of CanadaJ Natl Cancer Inst20009220521610655437
   PubMed Web of Science ®Google Scholar
• KimuraHKasaharaKKawaishiMDetection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small-cell lung cancerClin Cancer Res200612133915392116818687
   PubMed Web of Science ®Google Scholar
• ZhangJLiangZYZengXWuSFGaoJLiuTHDetection of epidermal growth factor receptor gene mutations in non-small cell lung cancers by real-time polymerase chain reaction using scorpion amplification refractory mutation systemZhonghua Bing Li Xue Za Zhi2008375294299 Chinese18956645
   PubMedGoogle Scholar
• LiGLuoXHeJA novel liquidchip platform for simultaneous detection of 70 alleles of DNA somatic mutations on EGFR, KRAS, BRAF and PIK3CA from formalin-fixed and paraffin-embedded slides containing tumor tissueClin Chem Lab Med201149219119521118047
   PubMed Web of Science ®Google Scholar
• ChinTMAnuarDSooRDetection of epidermal growth factor receptor variations by partially denaturing HPLCClin Chem2007531627017110474
   PubMed Web of Science ®Google Scholar
• CohenVAgulnikJSJarryJEvaluation of denaturing high-performance liquid chromatography as a rapid detection method for identification of epidermal growth factor receptor mutations in nonsmall-cell lung cancerCancer2006107122858286517096434
   PubMed Web of Science ®Google Scholar
• WuSZhuZHeJLuoXXuJRen-HeidenreichLA novel mutant-enriched liquidchip technology for the qualitative detection of somatic mutations in KRAS gene from both serum and tissue samplesClin Chem Lab Med20104881103110620482381
   PubMed Web of Science ®Google Scholar
• MitsudomiTKosakaTEndohHMutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrenceJ Clin Oncol200523112513252015738541
   PubMed Web of Science ®Google Scholar
• MokTSWuYLThongprasertSGefitinib or carboplatin-paclitaxel in pulmonary adenocarcinomaN Engl J Med20093611094795719692680
   PubMed Web of Science ®Google Scholar
• MaemondoMInoueAKobayashiKNorth-East Japan Study GroupGefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFRN Engl J Med2010362252380238820573926
   PubMed Web of Science ®Google Scholar
• GotoKIchinoseYOheYEpidermal growth factor receptor mutation status in circulating free DNA in serum: from IPASS, a phase III study of gefitinib or carboplatin/paclitaxel in non-small cell lung cancerJ Thorac Oncol20127111512121900837
   PubMed Web of Science ®Google Scholar
• MaheswaranSSequistLVNagrathSDetection of mutations in EGFR in circulating lung-cancer cellsN Engl J Med2008359436637718596266
   PubMed Web of Science ®Google Scholar